(Q43907948)

27 November 2017

Anti-atherogenic effects of the acyl-CoA:cholesterol acyltransferase inhibitor, avasimibe (CI-1011), in cultured primary human macrophages (English)

1 reference

27 November 2017

1 reference

Annabelle Rodriguez

1

1 reference

PubMed ID

11882316

27 November 2017

David C Usher

series ordinal

2

1 reference

27 November 2017

1 March 2002

1 reference

27 November 2017

1 reference

27 November 2017

161

1 reference

27 November 2017

1

1 reference

27 November 2017

45-54

1 reference

Novel effects of the acyl-coenzyme A:Cholesterol acyltransferase inhibitor 58-035 on foam cell development in primary human monocyte-derived macrophages

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900620-7

Disruption of the acyl-CoA:cholesterol acyltransferase gene in mice: evidence suggesting multiple cholesterol esterification enzymes in mammals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900620-7

Inhibitors of acyl-CoA: cholesterol O-acyl transferase (ACAT) as hypocholesterolemic agents. CI-1011: an acyl sulfamate with unique cholesterol-lowering activity in animals fed noncholesterol-supplemented diets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900620-7

Effect of the acyl-CoA:cholesterol acyltransferase inhibitor, E5324, on experimental atherosclerosis in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900620-7

The ACAT inhibitor avasimibe reduces macrophages and matrix metalloproteinase expression in atherosclerotic lesions of hypercholesterolemic rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900620-7

THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900620-7

Enhanced macrophage uptake of low density lipoprotein after self-aggregation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900620-7

A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900620-7

Short-term measurement of catabolic rates using iodine-labeled plasma proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900620-7

High-affinity uptake and degradation of ApoE-free high-density lipoprotein and low-density lipoprotein in cultured porcine hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900620-7

Cell toxicity induced by inhibition of acyl coenzyme A:cholesterol acyltransferase and accumulation of unesterified cholesterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900620-7

Apolipoprotein E produced by human monocyte-derived macrophages mediates cholesterol efflux that occurs in the absence of added cholesterol acceptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900620-7

Effects of intracellular free cholesterol accumulation on macrophage viability: a model for foam cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900620-7

Aggregated low density lipoprotein induces and enters surface-connected compartments of human monocyte-macrophages. Uptake occurs independently of the low density lipoprotein receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900620-7

The secretion of apolipoprotein E by human monocytederived macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900620-7

Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900620-7

10.1016/S0021-9150(01)00620-7

7 January 2021

Identifiers

DOI

1 reference

27 November 2017

1 reference

PubMed ID

11882316